Cargando…

Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis

Nutrigenomics is a relatively new branch of nutrition science, which aim is to study the impact of the foods we eat on the function of our genes. Hepatosteatosis is strongly associated with hepatitis C virus infection, which is known to increase the risk of the disease progression and reduce the lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qing, Bengmark, Stig, Qu, Shen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896340/
https://www.ncbi.nlm.nih.gov/pubmed/20487553
http://dx.doi.org/10.1186/1471-230X-10-49
_version_ 1782183337564045312
author Liu, Qing
Bengmark, Stig
Qu, Shen
author_facet Liu, Qing
Bengmark, Stig
Qu, Shen
author_sort Liu, Qing
collection PubMed
description Nutrigenomics is a relatively new branch of nutrition science, which aim is to study the impact of the foods we eat on the function of our genes. Hepatosteatosis is strongly associated with hepatitis C virus infection, which is known to increase the risk of the disease progression and reduce the likelihood of responding to anti- virus treatment. It is well documented that hepatitis C virus can directly alter host cell lipid metabolism through nuclear transcription factors. To date, only a limited number of studies have been on the effect of human foods on the nuclear transcription factors of hepatitis C virus -induced hepatosteatosis. Three nutrients, selected among 46 different nutrients: β-carotene, vitamin D(2), and linoleic acid were found in a cell culture system to inhibit hepatitis C virus RNA replication. In addition, polyunsaturated fatty acids (PUFAs) especially arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) have been demonstrated to inhibit hepatitis C virus RNA replication. These PUFAs, in particular the highly unsaturated n-3 fatty acids change the gene expression of PPARa and SREBP, suppress the expression of mRNAs encoding key metabolic enzymes and hereby suppress hepatic lipogenesis and triglyceride synthesis, as well as secretion and accumulation in tissues. A recent prospective clinical trial of 1,084 chronic hepatitis C patients compared to 2,326 healthy subjects suggests that chronic hepatitis C patients may benefit from strict dietary instructions. Increasing evidence suggest that some crucial nuclear transcription factors related to hepatitis C virus -associated hepatosteatosis and hepatitis C virus RNA itself can be controlled by specific anti- hepatitis C virus nutrition. It seems important that these findings are taken into account and specific nutritional supplements developed to be used in combination with interferon as adjunctive therapy with the aim to improve both the early as well as the sustained virological response.
format Text
id pubmed-2896340
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28963402010-07-03 Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis Liu, Qing Bengmark, Stig Qu, Shen BMC Gastroenterol Review Nutrigenomics is a relatively new branch of nutrition science, which aim is to study the impact of the foods we eat on the function of our genes. Hepatosteatosis is strongly associated with hepatitis C virus infection, which is known to increase the risk of the disease progression and reduce the likelihood of responding to anti- virus treatment. It is well documented that hepatitis C virus can directly alter host cell lipid metabolism through nuclear transcription factors. To date, only a limited number of studies have been on the effect of human foods on the nuclear transcription factors of hepatitis C virus -induced hepatosteatosis. Three nutrients, selected among 46 different nutrients: β-carotene, vitamin D(2), and linoleic acid were found in a cell culture system to inhibit hepatitis C virus RNA replication. In addition, polyunsaturated fatty acids (PUFAs) especially arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) have been demonstrated to inhibit hepatitis C virus RNA replication. These PUFAs, in particular the highly unsaturated n-3 fatty acids change the gene expression of PPARa and SREBP, suppress the expression of mRNAs encoding key metabolic enzymes and hereby suppress hepatic lipogenesis and triglyceride synthesis, as well as secretion and accumulation in tissues. A recent prospective clinical trial of 1,084 chronic hepatitis C patients compared to 2,326 healthy subjects suggests that chronic hepatitis C patients may benefit from strict dietary instructions. Increasing evidence suggest that some crucial nuclear transcription factors related to hepatitis C virus -associated hepatosteatosis and hepatitis C virus RNA itself can be controlled by specific anti- hepatitis C virus nutrition. It seems important that these findings are taken into account and specific nutritional supplements developed to be used in combination with interferon as adjunctive therapy with the aim to improve both the early as well as the sustained virological response. BioMed Central 2010-05-20 /pmc/articles/PMC2896340/ /pubmed/20487553 http://dx.doi.org/10.1186/1471-230X-10-49 Text en Copyright ©2010 Liu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Liu, Qing
Bengmark, Stig
Qu, Shen
Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
title Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
title_full Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
title_fullStr Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
title_full_unstemmed Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
title_short Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
title_sort nutrigenomics therapy of hepatisis c virus induced-hepatosteatosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896340/
https://www.ncbi.nlm.nih.gov/pubmed/20487553
http://dx.doi.org/10.1186/1471-230X-10-49
work_keys_str_mv AT liuqing nutrigenomicstherapyofhepatisiscvirusinducedhepatosteatosis
AT bengmarkstig nutrigenomicstherapyofhepatisiscvirusinducedhepatosteatosis
AT qushen nutrigenomicstherapyofhepatisiscvirusinducedhepatosteatosis